These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32003141)

  • 21. Luteal phase support for assisted reproduction cycles.
    van der Linden M; Buckingham K; Farquhar C; Kremer JA; Metwally M
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009154. PubMed ID: 26148507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prenatal administration of progestogens for preventing spontaneous preterm birth in women with a multiple pregnancy.
    Dodd JM; Grivell RM; OBrien CM; Dowswell T; Deussen AR
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012024. PubMed ID: 29086920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A feasibility trial of screening women with idiopathic recurrent miscarriage for high uterine natural killer cell density and randomizing to prednisolone or placebo when pregnant.
    Tang AW; Alfirevic Z; Turner MA; Drury JA; Small R; Quenby S
    Hum Reprod; 2013 Jul; 28(7):1743-52. PubMed ID: 23585559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An economic evaluation of outpatient versus inpatient polyp treatment for abnormal uterine bleeding.
    Diwakar L; Roberts TE; Cooper NA; Middleton L; Jowett S; Daniels J; Smith P; Clark TJ;
    BJOG; 2016 Mar; 123(4):625-31. PubMed ID: 26011792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progestogens in the prevention of miscarriage.
    Carp HJ
    Horm Mol Biol Clin Investig; 2016 Aug; 27(2):55-62. PubMed ID: 26677905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Androgens (dehydroepiandrosterone or testosterone) for women undergoing assisted reproduction.
    Nagels HE; Rishworth JR; Siristatidis CS; Kroon B
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD009749. PubMed ID: 26608695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study.
    Wu O; Robertson L; Twaddle S; Lowe GD; Clark P; Greaves M; Walker ID; Langhorne P; Brenkel I; Regan L; Greer I
    Health Technol Assess; 2006 Apr; 10(11):1-110. PubMed ID: 16595080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glyceryl trinitrate to reduce the need for manual removal of retained placenta following vaginal delivery: the GOT-IT RCT.
    Denison FC; Carruthers KF; Hudson J; McPherson G; Scotland G; Brook-Smith S; Clarkson C; Peace M; Brewin J; Chua GN; Hallowell N; Norman JE; Lawton J; Norrie J
    Health Technol Assess; 2019 Dec; 23(70):1-72. PubMed ID: 31912780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Supplementation with progestogens in the first trimester of pregnancy to prevent miscarriage in women with unexplained recurrent miscarriage: a systematic review and meta-analysis of randomized, controlled trials.
    Saccone G; Schoen C; Franasiak JM; Scott RT; Berghella V
    Fertil Steril; 2017 Feb; 107(2):430-438.e3. PubMed ID: 27887710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Economic evaluation of alternative management methods of first-trimester miscarriage based on results from the MIST trial.
    Petrou S; Trinder J; Brocklehurst P; Smith L
    BJOG; 2006 Aug; 113(8):879-89. PubMed ID: 16827823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Double-blind randomized trial of progesterone to prevent preterm birth in second-trimester bleeding.
    Salim R; Hakim M; Zafran N; Nachum Z; Romano S; Garmi G
    Acta Obstet Gynecol Scand; 2019 Oct; 98(10):1318-1325. PubMed ID: 31087325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of preterm delivery with vaginal progesterone in women with preterm labour (4P): randomised double-blind placebo-controlled trial.
    Martinez de Tejada B; Karolinski A; Ocampo MC; Laterra C; Hösli I; Fernández D; Surbek D; Huespe M; Drack G; Bunader A; Rouillier S; López de Degani G; Seidenstein E; Prentl E; Antón J; Krähenmann F; Nowacki D; Poncelas M; Nassif JC; Papera R; Tuma C; Espoile R; Tiberio O; Breccia G; Messina A; Peker B; Schinner E; Mol BW; Kanterewicz L; Wainer V; Boulvain M; Othenin-Girard V; Bertolino MV; Irion O;
    BJOG; 2015 Jan; 122(1):80-91. PubMed ID: 25209926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of metformin to treat pregnant women with polycystic ovary syndrome (PregMet2): a randomised, double-blind, placebo-controlled trial.
    Løvvik TS; Carlsen SM; Salvesen Ø; Steffensen B; Bixo M; Gómez-Real F; Lønnebotn M; Hestvold KV; Zabielska R; Hirschberg AL; Trouva A; Thorarinsdottir S; Hjelle S; Berg AH; Andræ F; Poromaa IS; Mohlin J; Underdal M; Vanky E
    Lancet Diabetes Endocrinol; 2019 Apr; 7(4):256-266. PubMed ID: 30792154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peri-conceptional progesterone treatment in women with unexplained recurrent miscarriage: a randomized double-blind placebo-controlled trial.
    Ismail AM; Abbas AM; Ali MK; Amin AF
    J Matern Fetal Neonatal Med; 2018 Feb; 31(3):388-394. PubMed ID: 28114846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does progesterone prophylaxis to prevent preterm labour improve outcome? A randomised double-blind placebo-controlled trial (OPPTIMUM).
    Norman JE; Marlow N; Messow CM; Shennan A; Bennett PR; Thornton S; Robson SC; McConnachie A; Petrou S; Sebire NJ; Lavender T; Whyte S; Norrie J
    Health Technol Assess; 2018 Jun; 22(35):1-304. PubMed ID: 29945711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment options for threatened miscarriage.
    Qureshi NS
    Maturitas; 2009 Dec; 65 Suppl 1():S35-41. PubMed ID: 19945236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uterotonic drugs to prevent postpartum haemorrhage: a network meta-analysis.
    Gallos I; Williams H; Price M; Pickering K; Merriel A; Tobias A; Lissauer D; Gee H; Tunçalp Ö; Gyte G; Moorthy V; Roberts T; Deeks J; Hofmeyr J; Gülmezoglu M; Coomarasamy A
    Health Technol Assess; 2019 Feb; 23(9):1-356. PubMed ID: 30821683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of transvaginal ultrasound cervical length screening in singletons without a prior preterm birth: an update.
    Werner EF; Hamel MS; Orzechowski K; Berghella V; Thung SF
    Am J Obstet Gynecol; 2015 Oct; 213(4):554.e1-6. PubMed ID: 26071914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sporadic pregnancy loss and recurrent miscarriage.
    Devall AJ; Coomarasamy A
    Best Pract Res Clin Obstet Gynaecol; 2020 Nov; 69():30-39. PubMed ID: 32978069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
    Lethaby A; Hussain M; Rishworth JR; Rees MC
    Cochrane Database Syst Rev; 2015 Apr; (4):CD002126. PubMed ID: 25924648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.